Pharmagreen Biotech Inc.
PHBI
$0.0011
$0.000.00%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 60.00% | -16.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 60.00% | -16.67% | |||
| Cost of Revenue | 25.00% | -20.00% | |||
| Gross Profit | 300.00% | 0.00% | |||
| SG&A Expenses | 22.38% | -11.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.40% | -11.79% | |||
| Operating Income | -21.83% | 11.73% | |||
| Income Before Tax | 181.29% | -1,728.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 181.29% | -1,728.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 181.29% | -1,733.18% | |||
| EBIT | -21.83% | 11.73% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 183.33% | -1,100.00% | |||
| Normalized Basic EPS | 185.71% | -- | |||
| EPS Diluted | 183.33% | -1,100.00% | |||
| Normalized Diluted EPS | 185.71% | -- | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
